<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35351756</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-790X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>29</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMJ case reports</Title>
          <ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antisynthetase syndrome sine myositis presenting as severe acute respiratory failure.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e248358</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2021-248358</ELocationID>
        <Abstract>
          <AbstractText>A female in her late 40s presented to the emergency department during the COVID-19 pandemic with shortness of breath, fever and productive cough following a recent diagnosis of bilateral non-massive pulmonary emboli. She had elevated inflammatory markers and her chest X-ray revealed bilateral infiltrates. Her SARS-CoV-2 PCR was negative, and she was treated for community-acquired pneumonia. However, despite treatment she rapidly deteriorated and developed severe respiratory failure, requiring mechanical ventilation.On further investigation, she tested positive for anti-Jo-1 antibodies and a diagnosis of antisynthetase syndrome sine myositis was made. This led to successful treatment with high dose corticosteroids and intravenous immunoglobulin.This case highlights an uncommon presentation of a rare condition, as well as the benefits of working in a multidisciplinary team on the intensive care unit.</AbstractText>
          <CopyrightInformation>© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Archer</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-8015-4039</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Intensive Care Medicine, Kettering General Hospital, Kettering, UK chrisarcher94@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nazim</LastName>
            <ForeName>Khola</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Intensive Care Medicine, Kettering General Hospital, Kettering, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Panchatsharam</LastName>
            <ForeName>Selva</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Intensive Care Medicine, Kettering General Hospital, Kettering, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMJ Case Rep</MedlineTA>
        <NlmUniqueID>101526291</NlmUniqueID>
        <ISSNLinking>1757-790X</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C537778">Antisynthetase syndrome</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009220" MajorTopicYN="Y">Myositis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Adult intensive care</Keyword>
        <Keyword MajorTopicYN="N">Interstitial lung disease</Keyword>
        <Keyword MajorTopicYN="N">Rheumatology</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2024</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>5</Hour>
          <Minute>40</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35351756</ArticleId>
        <ArticleId IdType="pmc">PMC8966537</ArticleId>
        <ArticleId IdType="doi">10.1136/bcr-2021-248358</ArticleId>
        <ArticleId IdType="pii">15/3/e248358</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lai C-C, Tseng K-L, Ho C-H, et al. . Prognosis of patients with acute respiratory failure and prolonged intensive care unit stay. J Thorac Dis
2019;11:2051–7. 10.21037/jtd.2019.04.84</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/jtd.2019.04.84</ArticleId>
            <ArticleId IdType="pmc">PMC6588762</ArticleId>
            <ArticleId IdType="pubmed">31285898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellani G, Laffey JG, Pham T, et al. . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA
2016;315:788–800. 10.1001/jama.2016.0291</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2016.0291</ArticleId>
            <ArticleId IdType="pubmed">26903337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vincent JL, Sakr Y, Ranieri VM. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med
2003;31:S296–9. 10.1097/01.CCM.0000057906.89552.8F</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.CCM.0000057906.89552.8F</ArticleId>
            <ArticleId IdType="pubmed">12682455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ewig S, Torres A, Angeles Marcos M, Marcos M, et al. . Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J
2002;20:1254–62. 10.1183/09031936.02.01942001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.02.01942001</ArticleId>
            <ArticleId IdType="pubmed">12449182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antoine M, Milka M. Interstitial Lung Disease [Internet]. StatPearls, 2021. Available: https://www.ncbi.nlm.nih.gov/books/NBK541084/ [Accessed 30 Oct 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Watanabe K, Handa T, Tanizawa K, et al. . Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med
2011;105:1238–47. 10.1016/j.rmed.2011.03.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2011.03.022</ArticleId>
            <ArticleId IdType="pubmed">21514811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Liu X, Xie M, et al. . Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review. Respir Med
2020;165:105920. 10.1016/j.rmed.2020.105920</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2020.105920</ArticleId>
            <ArticleId IdType="pubmed">32174452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med
2016;23:218–26. 10.1097/CPM.0000000000000171</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CPM.0000000000000171</ArticleId>
            <ArticleId IdType="pmc">PMC5006392</ArticleId>
            <ArticleId IdType="pubmed">27594777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Debray M-P, Borie R, Revel M-P, et al. . Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings. Eur J Radiol
2015;84:516–23. 10.1016/j.ejrad.2014.11.026</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejrad.2014.11.026</ArticleId>
            <ArticleId IdType="pubmed">25541020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimachkie MM. Idiopathic inflammatory myopathies. J Neuroimmunol
2011;231:32–42. 10.1016/j.jneuroim.2010.10.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2010.10.013</ArticleId>
            <ArticleId IdType="pubmed">21093064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malik A, Hayat G, Kalia JS, et al. . Idiopathic inflammatory myopathies: clinical approach and management. Front Neurol
2016;7:1–19. 10.3389/fneur.2016.00064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2016.00064</ArticleId>
            <ArticleId IdType="pmc">PMC4873503</ArticleId>
            <ArticleId IdType="pubmed">27242652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zamora AC, Hoskote SS, Abascal-Bolado B, et al. . Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respir Med
2016;118:39–45. 10.1016/j.rmed.2016.07.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2016.07.009</ArticleId>
            <ArticleId IdType="pubmed">27578469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gusdorf L, Morruzzi C, Goetz J, et al. . Mechanics hands in patients with antisynthetase syndrome: 25 cases. Ann Dermatol Venereol
2019;146:19–25. 10.1016/j.annder.2018.11.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annder.2018.11.010</ArticleId>
            <ArticleId IdType="pubmed">30595338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marco JL, Collins BF. Clinical manifestations and treatment of antisynthetase syndrome. Best Pract Res Clin Rheumatol
2020;34:101503. 10.1016/j.berh.2020.101503</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.berh.2020.101503</ArticleId>
            <ArticleId IdType="pubmed">32284267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alqatari S, Riddell P, Harney S, et al. . MDA-5 associated rapidly progressive interstitial lung disease with recurrent pneumothoraces: a case report. BMC Pulm Med
2018;18. 10.1186/s12890-018-0622-8. [Epub ahead of print: Available from].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12890-018-0622-8</ArticleId>
            <ArticleId IdType="pmc">PMC5905122</ArticleId>
            <ArticleId IdType="pubmed">29665800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujisawa T. Management of Myositis-Associated interstitial lung disease. Medicina
2021;57. 10.3390/medicina57040347. [Epub ahead of print: Available from].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/medicina57040347</ArticleId>
            <ArticleId IdType="pmc">PMC8065549</ArticleId>
            <ArticleId IdType="pubmed">33916864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Z, Cao M, Plana MN, et al. . Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res
2013;65:1316–24. 10.1002/acr.21985</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.21985</ArticleId>
            <ArticleId IdType="pubmed">23908005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doyle TJ, Dhillon N, Madan R, et al. . Rituximab in the treatment of interstitial lung disease associated with antisynthetase syndrome: a multicenter retrospective case review. J Rheumatol
2018;45:841–50. 10.3899/jrheum.170541</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3899/jrheum.170541</ArticleId>
            <ArticleId IdType="pmc">PMC5984657</ArticleId>
            <ArticleId IdType="pubmed">29606668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi J, Li S, Yang H, et al. . Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol
2017;44:1051–7. 10.3899/jrheum.161480</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3899/jrheum.161480</ArticleId>
            <ArticleId IdType="pubmed">28461650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev
2014;13:367–71. 10.1016/j.autrev.2014.01.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2014.01.022</ArticleId>
            <ArticleId IdType="pmc">PMC3970575</ArticleId>
            <ArticleId IdType="pubmed">24424190</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
